Clinical Trial Update: Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF) [NA]

View source ↗

Summary

The ORBICA-AF trial is currently recruiting to compare cardioversion versus therapeutic ablation in persistent atrial fibrillation, sponsored by Barts & The Lon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiac Arrhythmia

Snippet

Sponsor: Barts & The London NHS Trust | Conditions: Persistent Atrial Fibrillation, Cardiac Arrhythmia | NA | Status: RECRUITING